A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial*

the IXORA-R Study Group

科研成果: 期刊稿件 › 文章 › 同行评审

74 引用 （Scopus）

指纹

探究 'A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial*' 的科研主题。它们共同构成独一无二的指纹。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases